Cargando…
MS3-1 IMPLEMENTATION OF GENE PANEL TESTING USING NEXT-GENERATION SEQUENCING
The advance of next-generation sequencers (NGS) has dramatically improved the performance of genomic analysis of clinical samples in cancer precision medicine. The practical use of gene panel testing for clinical applications has begun in Japan. At present, “OncomineTM Dx Target Test” is listed as a...
Autor principal: | Sakai, Kazuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213349/ http://dx.doi.org/10.1093/noajnl/vdz039.011 |
Ejemplares similares
-
Next generation sequencing‐based gene panel tests for the management of solid tumors
por: Nagahashi, Masayuki, et al.
Publicado: (2018) -
Parallel testing of several genes (panel-testing) in patients with ectodermal dysplasia using next-generation sequencing
por: Gabriel, HD, et al.
Publicado: (2012) -
MS3-2 TREATMENT STRATEGY BASED ON THE RESULTS OF GENE PANELS
por: Takeda, Masayuki
Publicado: (2019) -
Design and implementation of a custom next generation sequencing panel for selected vitamin D associated genes
por: Benson, Katherine Angela, et al.
Publicado: (2017) -
Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
por: Au, Chun Hang, et al.
Publicado: (2016)